文献速递外周动脉疾病

慢性肢体威胁性缺血患者股腘动脉支架闭塞的旁路移植与腔内治疗比较

Bypass vs endovascular treatment for occluded femoro-popliteal stents in patients with critical limb-threatening ischemia.
PubMed 文献 · J Vasc Surg · 2023-07-31

基于OUT-STEPP多中心注册研究,2016年1月至2021年12月14个中心共161例股腘动脉支架闭塞的慢性肢体威胁性缺血患者,46例(28.6%)接受开放旁路手术(OPEN组),115例(71.4%)接受腔内血运重建(ENDO组)。30天时OPEN组输血需求更高(36.9% vs 11.3%,P < .001),ICU停留和住院时间更长;5年时两组生存率、一期通畅率、二期通畅率、免于靶病变再狭窄率和保肢率均无显著差异。

要点

  • 30天时OPEN组输血需求高于ENDO组(36.9% vs 11.3%,P < .001)。
  • OPEN组平均ICU停留时间和住院时间均长于ENDO组(P < .001)。
  • 5年时两组生存率、一期通畅率、二期通畅率、免于靶病变再狭窄率和保肢率均无显著差异。

核心结论

  • 旁路移植和腔内治疗均能为慢性肢体威胁性缺血患者的股腘动脉支架内闭塞提供安全有效的通畅性恢复。
  • 开放手术与更长的住院时间和更多的输血使用相关。
  • 5年时旁路移植与腔内治疗在总体通畅率或保肢率方面无显著差异。

研究设计与样本

  • OUT-STEPP多中心注册研究,2016年1月至2021年12月14个中心共317例患者因症状性股腘动脉支架闭塞接受治疗,其中161例纳入分析。
  • 46例(28.6%)接受开放旁路手术(OPEN组),115例(71.4%)接受腔内血运重建(ENDO组)。
  • 评估30天早期结果,并使用对数秩检验比较估计的5年结局。

主要发现

  • 30天时两组主要不良心血管事件、急性肾损伤、再干预、大截肢和全因死亡率无差异。
  • OPEN组输血需求高于ENDO组(17例,36.9% vs 13例,11.3%;P < .001)。
  • OPEN组平均ICU停留时间(0.3 ± 0.9 vs 0天;P < .001)和平均住院时间(9.7 ± 5.8 vs 3.3 ± 1.4天;P < .001)均高于ENDO组。
  • 总体中位随访时间为33.1个月(四分位距14-49.5个月)。
  • 5年时两组生存率(OPEN组68.7% vs ENDO组68.8%;P = .27;对数秩检验统计量1.21)、一期通畅率(OPEN组56.3% vs ENDO组67.8%;P = .39;对数秩检验统计量0.75)、二期通畅率(OPEN组59.1% vs ENDO组77.8%;P = .24;对数秩检验统计量1.40)、免于靶病变再狭窄率(OPEN组56.8% vs ENDO组62.7%;P = .42;对数秩检验统计量0.65)和保肢率(OPEN组77.2% vs ENDO组90.4%;P = .17;对数秩检验统计量1.87)均无显著差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of the study was to compare the early and medium-term outcomes of bypass vs endovascular treatment of occluded femoro-popliteal stents in patients with chronic limb-threatening ischemia (the OUT-STEPP multicentric registry). METHODS: Between January 2016 and December 2021, 317 patients in 14 centers underwent treatment for a symptomatic occlusion of femoro-popliteal stent/stents. One hundred sixty-one patients were included into the present study: 46 (28.6%) underwent open bypass surgery (Group OPEN), and 115 (71.4%) underwent endovascular revascularization (Group ENDO). Early (30 days) results were assessed and compared between the two groups. Estimated 5-year outcomes were evaluated and compared with the log rank test. RESULTS: At 30 days, no differences were found in terms of major adverse cardiovascular events, acute kidney injury, reinterventions, major amputation, and all-cause mortality between the two groups. The need for blood transfusions was higher for patients in Group OPEN (17; 36.9% vs 13; 11.3%; P < .001). The mean length of intensive care unit stay and the mean hospital stay were higher for patients in Group OPEN ([0.3 ± 0.9 vs 0 days; P < .001] and [9.7 ± 5.8 vs 3.3 ± 1.4 days; P < .001], respectively). The overall median duration of follow-up was 33.1 months (interquartile range, 14-49.5 months). At 5 years, there were no differences between the two groups in terms of survival (68.7% Group OPEN vs 68.8% Group ENDO; P = .27; log-rank, 1.21), primary patency (56.3% Group OPEN vs 67.8% Group ENDO; P = .39; log-rank, 0.75), secondary patency (59.1% Group OPEN vs 77.8% Group ENDO; P = .24; log-rank, 1.40), absence of target lesion restenosis (56.8% Group OPEN vs 62.7% Group ENDO; P = .42; log-rank, 0.65), and limb salvage (77.2% Group OPEN vs 90.4% Group ENDO; P = .17; log-rank, 1.87). CONCLUSIONS: Both bypass and endovascular treatment provided safe and effective restoration of patency for femoro-popliteal in-stent occlusion in patients with chronic limb-threatening ischemia. Open surgery was associated with longer stay in hospital and increased use of blood transfusions. At 5 years, no significant differences were found in the rates of overall patency or limb salvage between bypass and endovascular treatment.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. D'Oria M, Berchiolli R, Gargiulo M, et al. Bypass vs endovascular treatment for occluded femoro-popliteal stents in patients with critical limb-threatening ischemia. J Vasc Surg. 2023. PMID: 37532160. doi:10.1016/j.jvs.2023.07.053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。